JOHNSON JOHN

CIK 000141078115 companiesINDIANAPOLIS, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001410781

Recent Transactions

50 trades

Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-12-19$7.22/sh−135,400→ 698,083 total
Sale
Axogen, Inc.$AXGN
Common Stock
2025-12-09$29.98/sh−8,545→ 13,141 total
Exercise/Conversion
Axogen, Inc.$AXGN
Common Stock
2025-12-09$6.30/sh+8,545→ 21,686 total
Sale
Axogen, Inc.$AXGN
Common Stock
2025-12-09$29.98/sh−13,141→ 0 total
Exercise/Conversion
Axogen, Inc.$AXGN
Stock Option (right to purchase)
2025-12-09−8,545→ 0 total
Sale
Axogen, Inc.$AXGN
Common Stock
2025-12-08$31.22/sh−11,891→ 13,141 total
Sale
Axogen, Inc.$AXGN
Common Stock
2025-12-08$31.26/sh−11,802→ 13,141 total
Exercise/Conversion
Axogen, Inc.$AXGN
Stock Option (right to purchase)
2025-12-08−11,891→ 8,545 total
Exercise/Conversion
Axogen, Inc.$AXGN
Common Stock
2025-12-08$6.30/sh+11,891→ 25,032 total
Sale
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-08-13$7.32/sh−107,500→ 833,483 total
Award
Axogen, Inc.$AXGN
Restricted Stock Units
2025-06-19+14,150→ 14,150 total
Sale
Axogen, Inc.$AXGN
Common Stock
2025-06-09$10.61/sh−4,073→ 24,943 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2025-06-04+50,000→ 940,983 total
Award
Verastem, Inc.$VSTM
Stock Option (right to buy)
2025-05-22+12,500→ 12,500 total
Award
Verastem, Inc.$VSTM
Common Stock
2025-05-22+8,333→ 16,666 total
Award
Applied Therapeutics, Inc.$APLT
Common Stock
2024-12-19+500,000→ 500,000 total
Award
Applied Therapeutics, Inc.$APLT
Stock Option (Right to Buy)
2024-12-19+1,000,000→ 1,000,000 total
Exercise/Conversion
Axogen, Inc.$AXGN
Common Stock
2024-09-01+11,904→ 29,016 total
Exercise/Conversion
Axogen, Inc.$AXGN
Restricted Stock Units
2024-09-01−11,904→ 0 total
Award
Verastem, Inc.$VSTM
Stock Option (right to buy)
2024-06-18+12,500→ 12,500 total
Award
Verastem, Inc.$VSTM
Common Stock
2024-06-18+8,333→ 8,333 total
Award
Axogen, Inc.$AXGN
Employee Stock Option (right to purchase)
2024-06-06+18,248→ 18,248 total
Award
Axogen, Inc.$AXGN
Common Stock
2024-06-06+10,653→ 17,112 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-06-05+50,000→ 890,983 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-03-18$1.99/sh+215,600→ 751,412 total
Exercise/Conversion
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2024-03-18−215,600→ 0 total
Other
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-03-15+89,571→ 840,983 total
Award
Verastem, Inc.$VSTM
Stock Option (right to buy)
2024-03-11+8,549→ 8,549 total
Disposition to Issuer
Verastem, Inc.$VSTM
Stock Option (right to buy)
2024-03-11−2,083→ 0 total
Disposition to Issuer
Verastem, Inc.$VSTM
Stock Option (right to buy)
2024-03-11−2,300→ 0 total
Disposition to Issuer
Verastem, Inc.$VSTM
Stock Option (right to buy)
2024-03-11−2,083→ 0 total
Disposition to Issuer
Verastem, Inc.$VSTM
Stock Option (right to buy)
2024-03-11−2,083→ 0 total
Award
Axogen, Inc.$AXGN
Stock Option (right to purchase)
2023-09-01+20,436→ 20,436 total
Award
Axogen, Inc.$AXGN
Restricted Stock Units
2023-09-01+11,904→ 11,904 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-06-07+42,500→ 535,812 total
Exercise/Conversion
Axogen, Inc.$AXGN
Restricted Stock Units
2023-06-01−6,459→ 0 total
Exercise/Conversion
Axogen, Inc.$AXGN
Common Stock
2023-06-01+6,459→ 6,459 total
Award
Verastem, Inc.$VSTM
Stock Option (right to buy)
2023-05-15+62,500→ 62,500 total
Award
Verastem, Inc.$VSTM
Stock Option (right to buy)
2022-06-22+62,500→ 62,500 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-06-08+15,000→ 493,312 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2022-06-08+25,000→ 25,000 total
Award
Axogen, Inc.$AXGN
Restricted Stock Units
2022-06-01+6,459→ 6,459 total
Award
Axogen, Inc.$AXGN
Employee Stock Option (right to purchase)
2022-06-01+11,811→ 11,811 total
Award
Verastem, Inc.$VSTM
Stock Option (right to buy)
2022-05-12+62,500→ 62,500 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+478,312→ 478,312 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+215,600→ 215,600 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+31,360→ 31,360 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+10,367→ 10,367 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+10,367→ 10,367 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05$2.37/sh+19,650→ 19,650 total

Companies

Recent Filings

Address

LILLY CORPORATE CENTER

INDIANAPOLIS, IN, 46285

View on SEC.gov